CDC Recommends Doxycycline Prophylaxis to Prevent STIs in US

JAMA. 2024 Jul 23;332(4):273. doi: 10.1001/jama.2024.11024.
No abstract available

Publication types

  • News

MeSH terms

  • Anti-Bacterial Agents* / therapeutic use
  • Antibiotic Prophylaxis
  • Centers for Disease Control and Prevention, U.S.
  • Doxycycline* / therapeutic use
  • Female
  • Gonorrhea / prevention & control
  • Humans
  • Male
  • Practice Guidelines as Topic
  • Sexual and Gender Minorities
  • Sexually Transmitted Diseases* / prevention & control
  • Transgender Persons
  • United States

Substances

  • Anti-Bacterial Agents
  • Doxycycline